Is carvedilol superior to propranolol in patients with cirrhosis with portal hypertension: a systematic and meta-analysis
Background: Carvedilol has shown greater potency than propranolol as a β-blocker in managing cardiac conditions. However, its efficacy in reducing portal hypertension (PHTN) in patients with cirrhosis remains unclear. This study evaluates the efficacy and safety of carvedilol compared with propranol...
Saved in:
| Main Authors: | Siddheesh Rajpurohit, Balaji Musunuri, Pooja Basthi Mohan, Ganesh Bhat, Shiran Shetty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2025-02-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/is-carvedilol-superior-to-propranolol-in-patients-with-cirrhosis-with-portal-hypertension-a-systematic-and-meta-analysis/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
by: Chuan Liu, et al.
Published: (2025-01-01) -
From invasive to intuitive: The emerging role of non-invasive models in hepatic decompensation: Editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”
by: Akhil Deshmukh, et al.
Published: (2025-04-01) -
The Impact of Heart Rate Reduction From Individual Baseline With Propranolol for Primary and Secondary Prophylaxis of Variceal Hemorrhage in Cirrhosis
by: Warunee Mingpun, et al.
Published: (2025-03-01) -
The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension
by: Elias Xirouchakis, et al.
Published: (2024-11-01) -
Perbandingan Efektivitas dan Keamanan Ligasi dengan atau Tanpa Propranolol pada Anak dengan Hipertensi Portal
by: Kadim Muzal, et al.
Published: (2025-04-01)